Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Comparison of Angiotensin-Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) for Heart Failure Treatment in Congenital Heart Diseases with Left-to-Right Shunt

The Indonesian Biomedical Journal · Vol. 12 No. 1 (2020) · pp. 62–68

DOI
10.18585/inabj.v12i1.997
ISSN
2085-3297, 2355-9179
Published
2020-03-19
Publisher
Secretariat of The Indonesian Biomedical Journal
Language
en
License
creativecommons.org/licenses/by-nc/4.0/

Abstract

BACKGROUND: The angiotensin-converting enzyme inhibitors (ACEIs) have become the forefront of heart failure treatment for more than a decade. Currently, angiotensin receptor blockers (ARBs) are thought to have similar effectiveness. This study aimed to compare the impact of captopril, one of ACEI, and valsartan, one of ARB, on clinical presentation and echocardiographic, electrocardiographic, and chest x-ray improvement in patients with left-to-right shunt congenitalheart diseases.METHODS: This study used a double-blind randomized controlled trial of captopril and valsatran to children with left-to-right shunt congenital heart diseases who suffer from heart failure in the Dr. Soetomo General Hospital, Surabaya, Indonesia. Pediatric heart failure scores, echocardiography, electrocardiography (ECG), and chest photographs were examined at the beginning of the study and after 30 days of treatment.RESULTS: A decrease in pediatric heart failure scores were showed after the administration of ACEI (7.06±2.04 vs. 4.75±2.43; p<0.0001; 95% CI: −2.98 - 1.65); ARB (6.81±2.25 vs. 3.94±1.98; p<0.0001; 95% CI: −3.76 to 1.98). The echocardiography examination, an increase in left ventricular end-diastolic volume (LVEDV), left ventricular ejection fraction (LVEF), % fractional shortening (FS), and left ventricular (LV) dimension occurred after the administration of ACEI and ARB. The values also didn’t significantly differrent between the two groups. The ECG evaluation showed a decrease in heart rate frequency after the administration of ACEI (117.75±14.67 vs. 109.63±17.59; p=0.039; 95% CI: −15.78 to −0.46) and ARB (117.10±21.86 vs.108.6±20.66; p=0.006; 95% CI: −14.17 to −2.83).CONCLUSION: ARB showed better outcome in clinical condition, echocardiography, ECG, and chest radiographs.KEYWORDS: captopril, valsartan, heart failure, congenital heart disease, left to right shunt

Keywords

Collaboration network of the authors

23 authors · 73 co-authorship links · 16 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Warmadewa University
  • University of Indonesia
  • Universitas Syiah Kuala
  • STIKES Yayasan RS Dr. Soetomo
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Bagus SetyoboediUniversitas Airlangga2
Md. Atiar RahmanAffiliation unknown2
Arie PurwanaWarmadewa University1
Jose R. L. BatubaraUniversity of Indonesia1
Muhammad FaiziUniversitas Airlangga1
Prima Ardiansah SuryaUniversitas Airlangga1
Marsheila Harvy MustikaningtyasUniversitas Airlangga1
Sacharissa Zerlina Tsarwah ThirafiUniversitas Airlangga1
Afika Danedea PramithaUniversitas Airlangga1
Laksita Taffara MahdyUniversitas Airlangga1
Gery Morales MuntheUniversitas Airlangga1
Adivia Cheries DwiantoroUniversitas Airlangga1
Erwin Astha TriyonoUniversitas Airlangga1
Sarah FirdausaUniversitas Syiah Kuala1
Joni SusantoUniversitas Airlangga1
Heru PrasetyoUniversitas Airlangga1
James HutagalungUniversitas Airlangga1
Lilis MasyfufahSTIKES Yayasan RS Dr. Soetomo1
Ivan HoesadaAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Comparison of Angiotensin-Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) for Heart Failure Treatment in Congenital Heart Diseases with Left-to-Right Shunt</dc:title><dc:creator>I Ketut Alit Utamayasa</dc:creator><dc:creator>Mahrus Ahmad Rahman</dc:creator><dc:creator>Teddy Ontoseno</dc:creator><dc:creator>Budiono Budiono</dc:creator><dc:subject>ACE inhibitors</dc:subject><dc:subject>angiotensin receptor blockers</dc:subject><dc:subject>captopril</dc:subject><dc:subject>valsartan</dc:subject><dc:subject>heart failure</dc:subject><dc:subject>congenital heart disease</dc:subject><dc:subject>left-to-right shunt</dc:subject><dc:subject>pediatric heart failure</dc:subject><dc:subject>left ventricular ejection fraction</dc:subject><dc:subject>left ventricular end-diastolic volume</dc:subject><dc:subject>heart rate</dc:subject><dc:subject>children with heart disease</dc:subject><dc:subject>echocardiography</dc:subject><dc:subject>electrocardiogram</dc:subject><dc:description xml:lang="en">BACKGROUND: The angiotensin-converting enzyme inhibitors (ACEIs) have become the forefront of heart failure treatment for more than a decade. Currently, angiotensin receptor blockers (ARBs) are thought to have similar effectiveness. This study aimed to compare the impact of captopril, one of ACEI, and valsartan, one of ARB, on clinical presentation and echocardiographic, electrocardiographic, and chest x-ray improvement in patients with left-to-right shunt congenitalheart diseases.METHODS: This study used a double-blind randomized controlled trial of captopril and valsatran to children with left-to-right shunt congenital heart diseases who suffer from heart failure in the Dr. Soetomo General Hospital, Surabaya, Indonesia. Pediatric heart failure scores, echocardiography, electrocardiography (ECG), and chest photographs were examined at the beginning of the study and after 30 days of treatment.RESULTS: A decrease in pediatric heart failure scores were showed after the administration of ACEI (7.06±2.04 vs. 4.75±2.43; p&lt;0.0001; 95% CI: −2.98 - 1.65); ARB (6.81±2.25 vs. 3.94±1.98; p&lt;0.0001; 95% CI: −3.76 to 1.98). The echocardiography examination, an increase in left ventricular end-diastolic volume (LVEDV), left ventricular ejection fraction (LVEF), % fractional shortening (FS), and left ventricular (LV) dimension occurred after the administration of ACEI and ARB. The values also didn’t significantly differrent between the two groups. The ECG evaluation showed a decrease in heart rate frequency after the administration of ACEI (117.75±14.67 vs. 109.63±17.59; p=0.039; 95% CI: −15.78 to −0.46) and ARB (117.10±21.86 vs.108.6±20.66; p=0.006; 95% CI: −14.17 to −2.83).CONCLUSION: ARB showed better outcome in clinical condition, echocardiography, ECG, and chest radiographs.KEYWORDS: captopril, valsartan, heart failure, congenital heart disease, left to right shunt</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2020-03-19</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v12i1.997</dc:identifier><dc:identifier>10.18585/inabj.v12i1.997</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 12 No 1 (2020); 62-68</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/997/467</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>